TP53 and cancer: A study conducted using a mouse model of pancreatic ductal adenocarcinoma found that sporadic loss of heterozygosity in Trp53 (the mouse p53 gene) occurs before cancer onset and leads to the acquisition of malignant properties facilitated by p53 inactivation.